This Next Generation Translational Proteomics for Alzheimer’s and Related Dementias program is funded by a grant expected to total $15.9 million over five years from the National Institute on Aging at the National Institutes of Health.
Several research labs at the University of Washington School of Medicine and Stanford University are pooling their protein science expertise in this program. Their area – proteomics -- is the large-scale analysis of proteins, including their abundance, structure, and function in a biological system
Creation of novel reagents to help characterize proteins that might play a role in the brain pathology of Alzheimer’s, led by David Baker, professor of biochemistry and director of the UW Medicine Institute of Protein Design. For example, this institute is computationally designing novel reagents targeted to CSF proteins. The reagents would be widely shared to detect-and-capture proteins for molecular analysis